Roughly one in four people taking itraconazole experiences at least one side effect, with stomach and bowel complaints topping the list and liver problems a distant but more worrying concern. A study of 227 patients on itraconazole therapy found that about 28% developed a side effect, the most frequent being liver enzyme elevations, nausea or vomiting, and diarrhea.1PubMed. Side effects associated with itraconazole therapy Most of these reactions are mild and resolve when the dose is lowered or the drug is stopped, but a handful of rarer effects deserve attention, especially during longer courses of treatment.
Stomach and Bowel Problems Are the Most Common Complaint
The side effects you are most likely to notice first are gastrointestinal. Nausea, vomiting, and diarrhea each affect roughly 6 to 7 percent of patients.2PubMed. Side effects associated with itraconazole therapy An older study of 189 patients on chronic itraconazole found an even higher overall rate of side effects at 39%, with mild gastrointestinal reactions being the most common by a wide margin.3Journal of Antimicrobial Chemotherapy. Adverse events associated with itraconazole in 189 patients on chronic therapy The difference in rates likely reflects how side effects are counted and how long patients take the drug, but the pattern is consistent: gut symptoms are the price of admission for a significant minority of users.
In a head-to-head trial comparing itraconazole to voriconazole in stem-cell transplant patients, vomiting hit about 17% of itraconazole users, nausea about 16%, and diarrhea about 10%.4PubMed Central. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation Those rates are higher than in less-sick populations, which makes sense: transplant patients are already dealing with damaged gut linings and cocktails of other drugs. For someone taking itraconazole for a toenail infection, the odds of significant nausea are lower, but it remains the single most frequent complaint across settings.
One detail worth knowing: among patients who did develop nausea and vomiting, blood levels of itraconazole were markedly higher than in those who tolerated the drug well, with a median serum concentration of about 5.3 mcg/mL versus 1.8 mcg/mL in patients without side effects.5Journal of Antimicrobial Chemotherapy. Side effects associated with itraconazole therapy That suggests gut symptoms are at least partly dose-dependent, and a dose reduction can genuinely help.
Liver Effects Range from Mild Enzyme Bumps to Rare Serious Injury
Hepatotoxicity is the side effect that gets the most attention in prescribing guides, even though it is not the most frequent one. In the 227-patient study, liver enzyme elevations occurred in about 7% of patients.6PubMed. Side effects associated with itraconazole therapy Most of these are mild, transient bumps that show up on blood work before you feel anything. The earlier chronic-use study similarly noted liver enzyme elevations as a less-common event compared to GI complaints, and rarely the cause of stopping the drug.7Journal of Antimicrobial Chemotherapy. Adverse events associated with itraconazole in 189 patients on chronic therapy
Genuine liver failure from itraconazole is exceedingly rare. A case report described a 46-year-old woman who developed hepatic failure while taking itraconazole for a nail infection. Her condition actually worsened after the drug was withdrawn, initially responding only to supportive care.8PubMed Central. Hepatic failure related to itraconazole use successfully treated by corticosteroids That case is notable precisely because it is unusual. Still, the rarity does not mean it should be ignored. Anyone on itraconazole for more than a few weeks should expect periodic liver function blood tests. A systematic review and meta-analysis found that once the drug’s trough blood level reaches about 1.0 mg/L, the risk of hepatotoxicity and other adverse events climbs.9PubMed Central. Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis Monitoring blood levels, where available, gives your doctor a way to keep the dose in a sweet spot that treats the infection without pushing liver risk higher than it needs to be.
Heart Concerns Are Taken Seriously
Itraconazole carries a boxed warning about heart failure, which sounds alarming but needs context. The drug has a direct negative inotropic effect, meaning it can reduce the force of the heart’s contractions. Laboratory work showed itraconazole decreased cardiac contractility in a way that suggests a direct action on heart muscle cells.10PubMed Central. Heart failure induced by itraconazole For someone with a healthy heart, this effect is unlikely to cause symptoms. For someone who already has weakened heart function, even a modest additional hit to contractility can tip them into fluid retention, leg swelling, and shortness of breath.
Because of this, itraconazole is generally avoided in people with existing heart failure or a history of it. If you have no cardiac history and are taking itraconazole for a short course, the cardiovascular risk is very low. The concern grows with higher doses, longer treatment, and pre-existing cardiac disease.
Peripheral Neuropathy on Longer Courses
Numbness, tingling, or weakness in your hands and feet is a side effect that most people do not associate with antifungal drugs, but it shows up more often than you might expect during prolonged treatment. A study of patients on long-term triazole antifungals for chronic aspergillosis found that 17% of those taking itraconazole developed peripheral neuropathy, compared with 9% on voriconazole and 3% on posaconazole.11PubMed. Peripheral neuropathy in patients on long-term triazole antifungal therapy Most episodes presented as numbness or tingling in the extremities, though a small number involved predominant leg weakness.12Journal of Antimicrobial Chemotherapy. Peripheral neuropathy in patients on long-term triazole antifungal therapy
In at least one reported case, a patient developed severe neuropathy along with peripheral edema while on itraconazole, a combination unusual enough to warrant its own case report.13PubMed Central. Itraconazole associated quadriparesis and edema: a case report The practical takeaway is that if you start noticing persistent tingling, numbness, or unexplained weakness in your limbs while taking itraconazole, mention it to your prescriber. This side effect is far more relevant for people taking the drug for months, not for a one-week course.
Skin Reactions
Skin side effects from itraconazole occur in an estimated 2% of cases, and most are mild. The documented range includes common rashes, hives, and very rarely more severe reactions.14PubMed Central. Itraconazole-associated purpuric drug eruption: a rare adverse effect of a commonly prescribed drug There is an interesting wrinkle here: at least one case report found that a patient who developed a rash on a generic formulation of itraconazole saw the rash improve after switching to the brand-name version, with rechallenge on the generic confirming the link.15PubMed Central. Skin rash during treatment with generic itraconazole That points to the possibility that inactive ingredients in certain generic formulations, not just the active drug, may contribute to skin reactions in some people.
Life-threatening skin reactions like Stevens-Johnson syndrome have been reported with itraconazole but are extremely rare. If you develop a spreading rash with blisters, mucous membrane involvement, or peeling skin, that warrants emergency care regardless of what medication you are taking.
A Hormonal Side Effect Most People Have Never Heard Of
One of the more unusual effects of itraconazole involves a condition called pseudohyperaldosteronism. The body behaves as though it has too much aldosterone, the hormone that controls sodium and potassium balance, even though aldosterone levels may be normal. Symptoms include high blood pressure, low potassium, fluid retention, and muscle weakness.
Research into the mechanism shows that itraconazole primarily causes this by blocking an enzyme called 11β-HSD2 that normally inactivates cortisol in the kidneys. When that enzyme is blocked, cortisol builds up and activates the mineralocorticoid receptor, mimicking the effects of excess aldosterone.16PubMed. Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals This is not something you would typically notice after a week or two of treatment, but it becomes relevant for patients on extended courses, particularly those already at risk for hypertension or potassium imbalances. If blood tests show dropping potassium or you develop unexplained swelling and rising blood pressure while on itraconazole, this mechanism may be the culprit.
Effects on Blood Cells
Drops in platelet counts (thrombocytopenia) and white blood cell counts (leukopenia) have been linked to itraconazole, though these remain uncommon. The association has been documented in case reports and pharmacovigilance data.17PubMed. Thrombocytopenia and leukopenia associated with itraconazole A separate review examining rare serious adverse events found individual cases of thrombocytopenia and neutropenia in which a drug-related cause could not be excluded.18PubMed. Itraconazole and fluconazole and certain rare, serious adverse events These effects would typically be picked up on routine blood work before you notice anything, which is another reason periodic monitoring matters during longer courses.
Drug Interactions Are a Bigger Risk Than Most Side Effects
Itraconazole is a potent inhibitor of the liver enzyme CYP3A4, which is responsible for breaking down a huge number of other medications. When itraconazole blocks that enzyme, blood levels of those other drugs can rise sharply, sometimes to dangerous concentrations. This is not a theoretical concern. Simulation studies have shown that coadministering itraconazole with certain statins roughly doubled the blood levels of the statin and its metabolites.19Drugs and Drug Candidates. Simulation of Plasma Level Changes in Cerivastatin and Its Metabolites, Particularly Cerivastatin Lactone, Induced by Coadministration with CYP2C8 Inhibitor Gemfibrozil, CYP3A4 Inhibitor Itraconazole, or Both, Using the Metabolite-Linked Model
Itraconazole also inhibits P-glycoprotein, a transport protein that pumps drugs out of cells and back into the gut. A study found that itraconazole nearly tripled the blood levels of fexofenadine (a common antihistamine) by blocking this pump, even though fexofenadine is not broken down by CYP3A4.20PubMed Central. Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein The practical implication is that you cannot assume a drug is safe to combine with itraconazole just because it is not metabolized by the same liver enzyme. The P-glycoprotein pathway is a second avenue for interactions that often gets overlooked.
The list of drugs that interact with itraconazole is long: certain blood thinners, some heart rhythm medications, sedatives, immunosuppressants, and some HIV drugs are all affected. Before starting itraconazole, a thorough medication review is essential. This is one of those situations where the interaction risk genuinely exceeds the drug’s own side-effect risk for many patients.
Absorption Quirks That Affect Both Effectiveness and Safety
Itraconazole capsules need stomach acid to dissolve properly. Anything that reduces acid in the stomach, including antacids, proton pump inhibitors, and H2 blockers, can dramatically cut the amount of drug that gets into your bloodstream. A study found that coadministering an antacid suspension slashed peak blood levels of itraconazole by roughly two-thirds.21PubMed. Reduced oral itraconazole bioavailability by antacid suspension Low blood levels have also been linked to concurrent use of rifampin and to administration through a nasogastric tube.22PubMed Central. Itraconazole: Precautions regarding drug interactions and bioavailability
This matters for side effects in two ways. First, poor absorption means the drug may not work, which can lead to treatment failure and the need for higher doses or longer courses, which in turn increases exposure and cumulative risk. Second, some people compensate by taking the drug with acidic drinks like cola, or their doctor switches them to the oral solution formulation, which does not need acid to be absorbed. The oral solution actually delivers higher blood levels than capsules, and if you are not aware of that difference, you could end up with unexpectedly high concentrations and more side effects.
Blood Levels and Monitoring
One theme running through the side-effect data is that higher blood levels of itraconazole predict more adverse events. In a propensity-matched comparison, patients who developed side effects had median serum levels of about 2.9 mcg/mL, significantly higher than the 1.8 mcg/mL seen in matched patients without side effects.23PubMed. Side effects associated with itraconazole therapy A systematic review separately identified a trough level of 1.0 mg/L as a threshold above which hepatotoxicity risk increases.24PubMed Central. Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
That said, the relationship is not perfectly clean. A wide range of blood levels was observed in both groups, meaning some people tolerate high levels without issues and others develop problems at levels that would be unremarkable in most patients.25Journal of Antimicrobial Chemotherapy. Side effects associated with itraconazole therapy Blood-level monitoring is most useful when treatment lasts more than a couple of weeks, when the patient is on other medications that might push levels up, or when side effects appear and the question is whether a dose adjustment might fix the problem rather than requiring a drug switch.
The median time to developing a side effect was about 45 days in the 227-patient study.26PubMed. Side effects associated with itraconazole therapy That means short courses for conditions like vaginal yeast infections carry much less risk than the months-long regimens used for nail fungus or chronic lung infections. If you are only on the drug for a week, many of the side effects discussed here become largely academic.
How Itraconazole Compares to Other Antifungals
Context helps. Itraconazole is not uniquely problematic among antifungals. In fact, a retrospective comparison found that fluconazole, often perceived as the gentler option, caused side effects in about 52% of patients being treated for coccidioidomycosis, with about 34% needing some change in therapy. Fluconazole also caused dry skin and hair loss, side effects that do not show up with itraconazole.27Journal of Antimicrobial Chemotherapy. Side effects associated with itraconazole therapy In the transplant trial, voriconazole caused more liver function abnormalities than itraconazole, though itraconazole caused more GI distress.28PubMed Central. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation Each antifungal has its own side-effect personality. Itraconazole’s profile leans toward gut symptoms, heart caution, and drug interactions. Voriconazole leans toward vision disturbances and liver stress. Fluconazole is better tolerated by most but has its own interaction list and can cause skin and hair issues at higher doses.
Pregnancy and Itraconazole
Itraconazole is generally avoided during pregnancy. Animal studies have shown it can cause birth defects, and human data, while limited, point in a concerning direction. A systematic review and meta-analysis of oral antifungal exposure during pregnancy found that itraconazole may increase the risk of eye defects in the fetus.29PubMed Central. Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: A systematic review and meta-analysis Congenital abnormalities and spontaneous abortions have also been reported in association with oral antifungals more broadly.30PubMed Central. Common Antifungal Drugs in Pregnancy: Risks and Precautions The evidence is not strong enough to say definitively how large the risk is, but it is strong enough that prescribers will reach for topical antifungals first during pregnancy whenever possible, reserving oral agents for serious systemic infections where the benefit clearly outweighs the fetal risk.
Women of childbearing potential who are prescribed itraconazole for a long course are typically advised to use effective contraception during treatment and for a period after stopping the drug, because itraconazole has a long half-life and lingers in the body for weeks after the last dose.
When Side Effects Lead to Stopping the Drug
Not every side effect means you have to quit. In the 227-patient cohort, about 19% of those who developed side effects had their dose reduced, while 46% ultimately had itraconazole discontinued.31PubMed. Side effects associated with itraconazole therapy That means roughly half of people who ran into trouble were able to continue at a lower dose or tolerate the effects long enough to complete treatment. The older chronic-therapy study similarly noted that toxicity rarely led to discontinuation despite the relatively high overall rate of adverse reactions.32Journal of Antimicrobial Chemotherapy. Adverse events associated with itraconazole in 189 patients on chronic therapy
The decision to push through, reduce, or stop depends on why you are taking the drug. If itraconazole is treating a potentially life-threatening lung infection, tolerating mild nausea makes sense. If it is treating toenail fungus, a cosmetic issue, even mild liver enzyme elevations might tip the scales toward stopping. Knowing which side effects are dose-related and which are idiosyncratic helps your prescriber make that call. Gut symptoms and pseudohyperaldosteronism tend to improve with dose reduction. Liver injury and severe skin reactions usually warrant stopping entirely.